HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
150571.0,217377,2159-09-19 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
   ------ Protected Section ------
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:14 AM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
   ------ Protected Section ------
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:14 AM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient, a 74-year-old male, is a vasculopath with a history of CABG, CVA, and bilateral carotid artery disease. He presented for right carotid stenting and had a vagal reaction during the procedure, requiring atropine and a nitro drip. He was transferred to the CCU with a controlled blood pressure (SBP) of 100. The patient's current medications include Coumadin, Lovenox, ASA, Plavix, Statin, Beta-Blocker, and Metoprolol.

The patient's vital signs are stable, with a temperature of 37.4Â°C, heart rate of 43 bpm, and blood pressure of 105/43 mmHg. His respiratory rate is 14 breaths per minute, and his SpO2 is 99%. He has a mild elevation in creatinine, and his hemoglobin is within normal limits.

The patient's physical examination is notable for oozing at the femoral catheter site, no bruit, and no hematoma. His neurologic examination is normal, with no residual effect from his CVA.

Potential medical complications:

1. Bleeding complications: The patient's oozing at the femoral catheter site may indicate a bleeding complication, which could lead to further bleeding or hematoma formation.
2. Thrombotic complications: The patient's history of carotid artery disease and recent stenting procedure may increase his risk of thrombotic complications, such as stroke or myocardial infarction.
3. Cardiac complications: The patient's history of CABG and recent stenting procedure may increase his risk of cardiac complications, such as heart failure or arrhythmias.
4. Neurologic complications: The patient's history of CVA and recent stenting procedure may increase his risk of neurologic complications, such as stroke or seizures.
5. Infection: The patient's catheterization and recent stenting procedure may increase his risk of infection, such as bacteremia or endocarditis.

Plan:

1. Monitor the patient's bleeding complications closely, and consider adjusting his anticoagulation therapy as necessary.
2. Continue to monitor the patient's cardiac and neurologic status, and adjust his medications as necessary to prevent complications.
3. Continue to monitor the patient's wound healing, and consider adjusting his anticoagulation therapy as necessary to prevent bleeding complications.
4. Consider restarting the patient's Coumadin therapy as an outpatient, and monitor his INR levels closely.
5. Continue to monitor the patient's creatinine levels, and adjust his medications as necessary to prevent further elevation."
150571.0,217377,2159-09-19 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
   ------ Protected Section ------
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:14 AM ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.  I also reviewed admit note from
   [**2159-9-18**]
   I would add the following remarks:
   History
   nothing to add
   Physical Examination
   nothing to add
   Medical Decision Making
   nothing to add
   Total time spent on patient care: 60 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:18 AM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
   ------ Protected Section ------
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:14 AM ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.  I also reviewed admit note from
   [**2159-9-18**]
   I would add the following remarks:
   History
   nothing to add
   Physical Examination
   nothing to add
   Medical Decision Making
   nothing to add
   Total time spent on patient care: 60 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-19**] 11:18 AM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old male who underwent right carotid stenting and has a history of coronary artery bypass grafting (CABG), cerebrovascular accident (CVA), and bilateral carotid artery disease. He is currently in the intensive care unit (ICU) for observation. The patient's vital signs are stable, with a blood pressure (BP) of 105/43 mmHg and a heart rate (HR) of 43 beats per minute (bpm). His respiratory rate (RR) is 14 inspirations per minute (ins/min), and his oxygen saturation (SpO2) is 99%. The patient's physical examination is unremarkable, with no signs of cardiac or respiratory distress.

Potential medical complications:

1. Hypotension: The patient's BP is slightly low, which may be a concern, especially given his history of CABG and CVA. Close monitoring of his BP and cardiovascular status is necessary to prevent hypotension.
2. Bleeding: The patient had some oozing at the femoral catheter site, which may be a sign of bleeding or hematoma formation. Close monitoring of the catheter site and bleeding is necessary to prevent further bleeding.
3. Infection: The patient is at risk of developing an infection, particularly given his history of CABG and CVA. Close monitoring of his temperature and white blood cell count is necessary to detect any signs of infection.
4. Thrombosis: The patient is at risk of developing thrombosis, particularly given his history of CABG and CVA. Close monitoring of his cardiovascular status and anticoagulation therapy is necessary to prevent thrombosis.
5. Respiratory complications: The patient's respiratory rate is slightly high, which may be a sign of respiratory distress. Close monitoring of his respiratory status and oxygen saturation is necessary to detect any signs of respiratory complications.

Plan:

1. Continue to monitor the patient's vital signs, including BP, HR, RR, and SpO2.
2. Continue to monitor the patient's catheter site and bleeding.
3. Continue to monitor the patient's temperature and white blood cell count to detect any signs of infection.
4. Continue to monitor the patient's cardiovascular status and anticoagulation therapy to prevent thrombosis.
5. Continue to monitor the patient's respiratory status and oxygen saturation to detect any signs of respiratory complications.
6. Continue to provide cardiac and diabetic diets, as well as anticoagulation therapy, as prescribed.
7. Continue to monitor the patient's hemoglobin and hematocrit levels to detect any signs of anemia or bleeding.
8. Continue to monitor the patient's creatinine levels to detect any signs of kidney damage.
9. Continue to monitor the patient's blood glucose levels to detect any signs of hyperglycemia or hypoglycemia.
10. Continue to provide education to the patient and his family on his condition, treatment, and follow-up care."
150571.0,217377,2159-09-19 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Left> right crackles at the bases.
   No wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight.
   Continue with Lovenox twice daily dosing until INR therapeutic.  Start
   home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Left> right crackles at the bases.
   No wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight.
   Continue with Lovenox twice daily dosing until INR therapeutic.  Start
   home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old male with a history of vasculopathy, CABG, CVA, and bilateral carotid artery disease, who presented for right carotid stenting. He had a vagal reaction during the procedure, which required atropine and a nitro drip. He was transferred to the CCU with an SBP of 100 off the nitro drip. The patient is currently being monitored for potential complications, including hypertension, bradycardia, and bleeding.

Potential Medical Complications:

1. Hypertension: The patient's SBP has been fluctuating, and it is crucial to maintain it within the target range of 90-120 mmHg to prevent complications.
2. Bleeding: The patient has experienced oozing at the femoral catheter site, which requires close monitoring and potential adjustments to anticoagulation therapy.
3. Bradycardia: The patient's heart rate has been slow, and it is essential to monitor for any signs of bradycardic sinus rhythm.
4. Cardiac arrhythmias: The patient has a history of PAF, and it is crucial to monitor for any signs of arrhythmias.
5. Anemia: The patient has a history of anemia, and it is essential to monitor for any signs of worsening anemia.
6. Hypoglycemia: The patient is being treated with glipizide and Humalog ISS, and it is crucial to monitor for signs of hypoglycemia.
7. Deep Vein Thrombosis (DVT): The patient is at risk for DVT due to his vasculopathy and anticoagulation therapy, and it is essential to monitor for any signs of DVT.
8. Pulmonary Embolism (PE): The patient is at risk for PE due to his vasculopathy and anticoagulation therapy, and it is essential to monitor for any signs of PE.

Recommendations:

1. Continue to monitor the patient's vital signs, including blood pressure, heart rate, and oxygen saturation.
2. Monitor the patient's bleeding risk and adjust anticoagulation therapy as necessary.
3. Monitor the patient's cardiac rhythm and adjust therapy as necessary.
4. Monitor the patient's anemia and adjust therapy as necessary.
5. Monitor the patient's blood glucose levels and adjust therapy as necessary.
6. Monitor the patient for signs of DVT and PE, and adjust therapy as necessary.
7. Consider adjusting the patient's medication regimen to better manage his hypertension, bleeding risk, and cardiac rhythm."
150571.0,217377,2159-09-19 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight.
   Continue with Lovenox twice daily dosing until INR therapeutic.  Start
   home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight.
   Continue with Lovenox twice daily dosing until INR therapeutic.  Start
   home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is a 74-year-old male who underwent right carotid stenting and has a history of vasculopathy, CABG, CVA with no residual effect, and bilateral carotid artery disease. He is currently in the ICU for observation.

The patient's vital signs are stable, with a temperature of 37.4Â°C, heart rate of 43 beats per minute, and blood pressure of 105/43 mmHg. His oxygen saturation is 99% on room air. His respiratory rate is 14 breaths per minute, and his lung examination is unlabored.

The patient's cardiac examination is notable for a junctional rhythm, and his cardiac enzymes are normal. His abdominal examination is normal, and his extremities are without signs of peripheral vascular disease.

The patient has a history of PAF, and he is currently in bradycardic sinus rhythm. He is on Coumadin as an outpatient and will restart this medication this evening.

The patient has a history of diabetes mellitus type II, and his hemoglobin A1C is 7.3%. He is not on insulin as an outpatient and will receive home dose glipizide and cover his sugars with Humalog SS while in the hospital.

The patient has a history of anemia, and his hemoglobin electrophoresis is normal. He is being monitored for anemia, and his hematocrit is being maintained at >30% given his CAD history.

Potential medical complications that can arise include:

1. Hypotension: The patient's blood pressure is currently controlled, but it is important to monitor it closely to prevent hypotension.
2. Bradycardia: The patient's junctional rhythm is stable, but it is important to monitor his heart rate closely to prevent bradycardia.
3. Thrombosis: The patient is at risk for thrombosis given his history of vasculopathy and carotid stenting. He is receiving Coumadin and Lovenox for prophylaxis.
4. Anemia: The patient has a history of anemia, and it is important to monitor his hematocrit closely to prevent anemia.
5. Hypoglycemia: The patient is receiving insulin and sulfonylurea, and he is at risk for hypoglycemia. It is important to monitor his blood glucose levels closely to prevent hypoglycemia.
6. Infection: The patient is at risk for infection given his history of CABG and carotid stenting. It is important to monitor him closely for signs of infection.

Overall, the patient is stable, but he requires close monitoring to prevent potential medical complications."
150571.0,217377,2159-09-19 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Post cath check at 2:30PM had some oozing at femoral cath site, no
   bruit, no hematoma; RUE site bandage c/d/i.
   -SBP overnight in the 60s when patient asleep->patient asysmptomatic
   and no intervention made.
   -This morning the patient denies any headaches, dizziness,
   lightheadedness, chest pain, shortness of breath.  He feels great and
   is motivated to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Coumadin (Warfarin) - [**2159-9-18**] 06:00 PM
   Enoxaparin (Lovenox) - [**2159-9-18**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-19**] 07:07 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 43 (42 - 55) bpm
   BP: 105/43(58) {80/28(41) - 108/47(59)} mmHg
   RR: 14 (10 - 24) insp/min
   SpO2: 99%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 94 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                  2,350 mL
                                                                    150 mL
   PO:
                                                                    450 mL
                                                                    150 mL
   TF:
   IVF:
                                                                  1,900 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    450 mL
   Urine:
                                                                    600 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,450 mL
                                                                   -300 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ////
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
        [image002.jpg]
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition: Cardiac/diabetic diet
   Glycemic Control: glipizide, Humalog ISS
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT: Coumadin, Lovenox
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:  CCU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old male with a history of vasculopathy, CABG, CVA, and bilateral carotid artery disease, who presented for right carotid stenting. He underwent the procedure without major complications, but had a vagal reaction requiring atropine and a nitro drip. He was transferred to the CCU with an SBP of 100 off the nitro drip. Currently, his vital signs are stable, with a temperature of 37.4Â°C, heart rate of 43 bpm, and blood pressure of 105/43 mmHg. He is receiving various medications, including Coumadin, Lovenox, ASA, Plavix, and metoprolol.

Potential Medical Complications:

1. Bleeding complications: The patient has ongoing bleeding at the femoral catheter site, which requires close monitoring.
2. Hypotension: The patient's SBP has been in the 60s overnight, and he is at risk for further hypotension, which may require intervention.
3. Cardiovascular complications: The patient has a history of CABG and CVA, and is at risk for further cardiovascular events, including myocardial infarction or stroke.
4. Pulmonary embolism: The patient is at risk for pulmonary embolism due to his vasculopathy and recent surgery.
5. Infection: The patient has a history of anemia and is at risk for infection, particularly with the use of invasive lines and catheters.
6. Medication interactions: The patient is taking multiple medications, including Coumadin, Lovenox, ASA, Plavix, and metoprolol, which may interact with each other and increase the risk of bleeding or other complications.
7. Respiratory complications: The patient has a history of respiratory problems, including COPD, and is at risk for further respiratory complications, including pneumonia or respiratory failure.

Recommendations:

1. Continue to monitor the patient's bleeding at the femoral catheter site and consider adjusting his anticoagulation therapy as needed.
2. Monitor the patient's SBP closely and consider adjusting his medication regimen to prevent further hypotension.
3. Continue to monitor the patient's cardiovascular status and consider adjusting his medication regimen to prevent further cardiovascular events.
4. Consider prophylactic anticoagulation therapy to prevent pulmonary embolism.
5. Monitor the patient's infection risk and consider adjusting his antibiotic regimen as needed.
6. Monitor the patient's medication interactions and consider adjusting his medication regimen to prevent bleeding or other complications.
7. Monitor the patient's respiratory status and consider adjusting his oxygen therapy as needed."
150571.0,217377,2159-09-20 06:19:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old male who was admitted to the ICU after undergoing a right carotid stenting procedure. He has a history of coronary artery bypass grafting (CABG), cerebrovascular accident (CVA) with no residual effect, and bilateral carotid artery disease. He presented with a vagal reaction during the procedure, which required atropine, and his blood pressure (SBP) increased to the 200s, requiring a nitro drip.

The patient's vital signs are stable, with a heart rate (HR) of 44-49 beats per minute, blood pressure of 103/46 mmHg, and oxygen saturation (SpO2) of 96%. His respiratory support is minimal, with no oxygen therapy or mechanical ventilation.

The patient's physical examination is notable for mild left lower leg edema, with no other significant findings. His laboratory results show mild anemia, with a hemoglobin level of 9.4 g/dL, and mild elevation of creatinine, with a level of 1.8 mg/dL.

The patient's medications include enoxaparin (Lovenox) for deep vein thrombosis (DVT) prophylaxis, aspirin (ASA) 325mg, clopidogrel (Plavix) 75mg, and warfarin (Coumadin) 5mg. He is also receiving a statin for hyperlipidemia and metformin for type 2 diabetes.

Potential medical complications that can arise:

1. Bleeding complications: The patient is receiving anticoagulation therapy with enoxaparin and warfarin, which increases the risk of bleeding complications.
2. Thrombosis: The patient is at risk for thrombosis due to his history of DVT and his current anticoagulation therapy.
3. Infection: The patient is at risk for infection due to his indwelling lines and his history of recent surgery.
4. Hypotension: The patient's blood pressure is currently well-controlled, but he is at risk for hypotension due to his history of vagal reactions and his current antihypertensive medications.
5. Arrhythmias: The patient has a history of atrial fibrillation (AF) and is currently in bradycardic sinus rhythm, which may increase his risk for arrhythmias.
6. Respiratory complications: The patient's mild left lower leg edema may increase his risk for respiratory complications, such as pneumonia.
7. Gastrointestinal complications: The patient's history of stress ulcer and his current use of antacids may increase his risk for gastrointestinal complications, such as bleeding or perforation.
8. Renal complications: The patient's mild elevation of creatinine may increase his risk for renal complications, such as acute kidney injury or chronic kidney disease.

Overall, the patient is at risk for various medical complications due to his underlying medical conditions and his current medications. Close monitoring and management are necessary to prevent or minimize these complications."
150571.0,217377,2159-09-20 06:19:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: Discharge today.  PCP f/u in two weeks
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I would add the following remarks:
   History
   Nothing to add
   Physical Examination
   Nothing to add
   Medical Decision Making
   Nothing to add
   Total time spent on patient care: 45 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-20**] 10:16 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: Discharge today.  PCP f/u in two weeks
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I would add the following remarks:
   History
   Nothing to add
   Physical Examination
   Nothing to add
   Medical Decision Making
   Nothing to add
   Total time spent on patient care: 45 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 862**] [**Name (NI) 3213**],MD
   on:[**2159-9-20**] 10:16 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following information is summarized:

The patient is a 74-year-old male who underwent right carotid stenting with a vagal reaction during the procedure. He was transferred to the CCU with a stable blood pressure and was started on nitroglycerin drip. He is currently being monitored for blood pressure control, with a goal of maintaining a systolic blood pressure between 90-120 mmHg.

The patient's laboratory results show:

* Hemoglobin: 12.4 g/dL
* Hematocrit: 37.5%
* Platelet count: 220,000/Î¼L
* Creatinine: 1.8 mg/dL
* Glucose: 93 mg/dL
* Calcium: 8.8 mg/dL
* Magnesium: 2.0 mg/dL
* Phosphorus: 3.8 mg/dL
* INR: 1.2

The patient's medications include:

* Aspirin 325mg daily
* Plavix 75mg daily
* Coumadin 5mg daily
* Lovenox 40mg daily
* Statin
* Metformin
* Glipizide
* Humalog SS
* Colace
* Senna
* Milk of magnesia

The patient's medical history includes:

* Coronary artery bypass graft (CABG)
* Cerebrovascular accident (CVA) with no residual effect
* Bilateral carotid artery disease
* Right carotid artery stenting

The patient's current conditions include:

* Vasculopathy
* Coronary artery disease
* Anemia
* Diabetes mellitus type II
* Hypertension
* Hyperlipidemia

Potential medical complications that can arise from the patient's conditions include:

* Cardiac complications such as myocardial infarction, heart failure, or arrhythmias
* Neurological complications such as stroke or transient ischemic attacks
* Vascular complications such as deep vein thrombosis or pulmonary embolism
* Gastrointestinal complications such as bleeding or perforation
* Infections such as pneumonia or urinary tract infections
* Metabolic complications such as hyperglycemia or hypoglycemia

The patient's current treatment plan includes:

* Maintenance of blood pressure control with nitroglycerin and/or dopamine as needed
* Anticoagulation therapy with Coumadin and Lovenox
* Antiplatelet therapy with aspirin and Plavix
* Statin therapy to manage hyperlipidemia
* Insulin therapy to manage hyperglycemia
* Colace and Senna to manage constipation
* Milk of magnesia to manage bowel movements

The patient is expected to be discharged today and will require follow-up with his primary care physician in two weeks."
150571.0,217377,2159-09-20 06:19:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: Discharge today.  PCP f/u in two weeks
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Walked this AM- got HR up to 60s.  Patient stable.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -          Pt bridging to Coumadin with Lovenox
   -          Will send home on KOH for 2 weeks (HR 40-110).
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: Discharge today.  PCP f/u in two weeks
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 74-year-old male who underwent right carotid stenting after presenting with symptoms of vasculopathy and a history of CABG, CVA, and bilateral carotid artery disease. The patient had a vagal reaction during the procedure, which required atropine, and his blood pressure (BP) increased to the 200s, requiring a nitro drip. He was transferred to the CCU with an SBP of 100 off the nitro drip.

The patient's current vital signs are:

* HR: 44 (42-49) bpm
* BP: 103/46 (59) mmHg
* Tcurrent: 36.8Â°C (98.2Â°F)
* Tmax: 37Â°C (98.6Â°F)
* SpO2: 96%
* RR: 16 (13-25) inspirations per minute

The patient's physical examination is notable for:

* Junctional rhythm (JR)
* Supple neck with a JVP of 8 cm
* PMI located in the 5th intercostal space, midclavicular line
* No chest wall deformities, scoliosis, or kyphosis
* Soft, non-tender abdomen
* No femoral bruits
* 1+ left and trace right lower leg edema
* Warm and well-perfused skin with normal capillary refill time

The patient's laboratory results are:

* WBC: 8.1, 8.0, 6.8
* Hct: 25.5, 24.5, 23.3
* Plt: 220, 185, 184
* Cr: 2.0, 2.1, 1.8
* Glucose: 58, 215, 93
* INR: 14.0, 29.1, 1.2
* Ca++: 8.8 mg/dL
* Mg++: 2.0 mg/dL
* PO4: 3.8 mg/dL

The patient's assessment and plan include:

* Maintaining SBP <120 and >90
* Continuing ASA 325mg and Plavix 75mg
* Resuming Coumadin 5mg tonight (INR down to 1.2 this AM)
* Continuing with Lovenox bridge to Coumadin until INR therapeutic
* Starting home dose Coumadin prior to discharge
* Continuing ASA, Plavix, and Statin
* D/C Beta blocker for now and monitoring HR with [**Doctor Last Name**] of Hearts monitor at home
* Cont [**Last Name (un) 284**] and D/C home atenolol
* Bridging to Coumadin with Lovenox
* Will send home on KOH for 2 weeks (HR 40-110)
* Will give home dose glipizide and cover the sugars with Humalog SS while in house
* Will hold home metformin
* Cont to monitor and maintain Hct >30 given CAD hx
* Full Code
* Discharge today with PCP f/u in two weeks

Potential medical complications that can arise include:

* Bleeding complications due to Coumadin and Lovenox therapy
* Increased risk of stroke or transient ischemic attack (TIA) due to carotid stenting
* Cardiac arrhythmias or decreased cardiac function due to beta blocker therapy
* Hypoglycemia or hyperglycemia due to changes in glucose control
* Anemia or worsening of existing anemia due to uncertainty of etiology and lack of clear treatment plan
* DVT or PE due to immobility and lack of prophylaxis
* VAP or stress ulcer due to prolonged ICU stay and immobility"
150571.0,217377,2159-09-20 06:19:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   - Pt bridging to Coumadin with Lovenox
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   HR continues to be in the 30s-50s overnight.  Patient is asymptomatic
   and anxious to go home.
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   cath site no hematoma or bruit.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 and
   patient symptomatic start dopamine.
   - Cont to follow Neuro Exam q6h
   - Continue ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight
   (INR down to 1.2 this AM).  Continue with Lovenox bridge to Coumadin
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, [**Last Name (un) 284**]
   - D/C Beta blocker for now and monitor HR with [**Doctor Last Name **] of Hearts monitor
   at home.
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   -          Cont [**Last Name (un) 284**],  D/C home atenolol
   -          If needs beta blocker in the future atenolol 150mg should be
   switched to metoprolol 75mg given the patient
s recent increased
   creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   - Pt bridging to Coumadin with Lovenox
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following information can be summarized:

The patient is a 74-year-old male who underwent right carotid stenting and experienced a vagal reaction during the procedure, requiring atropine and a nitro drip. He was transferred to the CCU and is currently being monitored for any complications.

The patient's vital signs are stable, with a heart rate of 44-49 bpm, blood pressure of 103/46 mmHg, and oxygen saturation of 96%. He has a junctional rhythm and is receiving enoxaparin (Lovenox) for DVT prophylaxis.

The patient's laboratory results show:

* White blood cell count: 8.1-6.8 K/uL
* Hemoglobin: 25.5-23.3 g/dL
* Platelet count: 220-184 K/uL
* Creatinine: 2.0-1.8 mg/dL
* Glucose: 58-93 mg/dL
* INR: 14.0-1.2
* Calcium: 8.8 mg/dL
* Magnesium: 2.0 mg/dL
* Phosphorus: 3.8 mg/dL

The patient's medical history includes:

* Coronary artery bypass graft (CABG) in 2154
* Cerebrovascular accident (CVA) with no residual effect
* Bilateral carotid artery disease
* Left carotid endarterectomy (CEA) in 2007
* Right carotid stenting

The patient's current medications include:

* Aspirin 325mg
* Plavix 75mg
* Coumadin 5mg
* Lovenox 10mg
* Statin
* Glipizide
* Humalog SS

Potential medical complications that can arise include:

* Bleeding due to Coumadin therapy
* Thrombocytopenia due to Lovenox therapy
* Hypoglycemia due to insulin therapy
* Hyperglycemia due to diabetes mellitus
* Anemia due to unclear etiology
* DVT or pulmonary embolism due to immobility
* Respiratory complications due to pneumonia or acute respiratory distress syndrome
* Cardiac complications due to coronary artery disease or heart failure

It is essential to monitor the patient's vital signs, laboratory results, and medication regimen closely to prevent or manage these potential complications."
150571.0,217377,2159-09-20 06:19:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   [**9-19**]- HR in high 30s/low 40s.  Plan on keeping patient overnight for
   further observation (patient and daughter notified).
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   [**9-19**]- HR in high 30s/low 40s.  Plan on keeping patient overnight for
   further observation (patient and daughter notified).
   Allergies:
   Enalapril
   Cough; angioede
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Enoxaparin (Lovenox) - [**2159-9-19**] 08:35 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2159-9-20**] 06:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.8
C (98.2
   HR: 44 (42 - 49) bpm
   BP: 103/46(59) {90/32(50) - 133/63(74)} mmHg
   RR: 16 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: JR (Junctional Rhythm)
   Wgt (current): 95.9 kg (admission): 94 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                  PO:
                                                                    830 mL
                  TF:
   IVF:
                                                                     10 mL
   Blood products:
   Total out:
                                                                  1,425 mL
                                                                    800 mL
   Urine:
                                                                  1,425 mL
                                                                    800 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -585 mL
                                                                   -800 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///22/
   Physical Examination
   GENERAL: pleasant male in NAD. Alert and oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. Crackles at the bases.  No wheezes
   or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.  RUE bandage is c/d/i.  RLE
   has some oozing at the cath site, no hematoma.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm and well
   perfused with normal capillary refill time.  1+ Left and trace right
   lower leg edema.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 2412**]: Carotid 2+ Femoral 2+ Popliteal 1+ DP, PT [**Name (NI) 2040**]
   [**Name (NI) 610**] / Radiology
   184 K/uL
   7.8 g/dL
   93 mg/dL
   1.8 mg/dL
   22 mEq/L
   3.8 mEq/L
   33 mg/dL
   104 mEq/L
   135 mEq/L
   23.3 %
   6.8 K/uL
        [image002.jpg]
                             [**2159-9-19**]  06:40 AM
                             [**2159-9-19**]  02:05 PM
                             [**2159-9-20**]  03:39 AM
   WBC
   8.1
   8.0
   6.8
   Hct
   25.5
   24.5
   23.3
   Plt
   220
   185
   184
   Cr
   2.0
   2.1
   1.8
   Glucose
   58
   215
   93
   Other [**Year (4 digits) **]: PT / PTT / INR:14.0/29.1/1.2, Ca++:8.8 mg/dL, Mg++:2.0
   mg/dL, PO4:3.8 mg/dL
   Assessment and Plan
   74M vasculopath with PMH of CABG in [**2154**], CVA with no residual effect,
   and bilateral carotid artery disease s/p left CEA [**7-3**] presenting for
   right carotid stenting.
   .
   # s/p RCA Stenting: Pt enrolled in [**Last Name (un) 7861**] study which is a
   ""multicenter, US surveillance registry designed to enroll a minimum of
   1,000 patients at up to 150 sites. The objective of the study is to
   compile early clinical outcomes data for the Wallstent and FilterWire
   EZ in routine clinical practice.""
   - Patient had a vagal reaction during the procedure which required
   atropine.  His SBP then went up to the 200s requiring a nitro drip.
   Otherwise he tolerated the procedure well and was transferred to the
   CCU with an SBP of 100 off the nitro drip.
   - Maintain SBP <120 and >90. If SBP>120 start nitro, if SBP<90 start
   dopamine.
   - Cont to follow Neuro Exam q1h for 2 hours, q2h for 2 checks, and then
   q6h
   - Check with study protocols regarding pt management protocols
   - start ASA 325mg and Plavix 75mg and resume Coumadin 5mg tonight (INR
   down to 1.2 this AM).  Continue with Lovenox treatment dose twice daily
   until INR therapeutic.  Start home dose Coumadin prior to discharge.
   - Post-cath check at 2:30PM showed some R femoral oozing, but no
   hematoma or bruit.  RUE cath site bandage is c/d/i.
   .
   # CORONARIES: Pt s/p CABG. Stress-MIBI without concerning ECG changes
   - Cont ASA, Plavix, Statin, Beta-Blocker, [**Last Name (un) 284**]
   .
   # PUMP: Last EF 60%. SBP currently well controlled.
   - Cont [**Last Name (un) 284**],  will switch home atenolol 150mg daily to metoprolol 75mg
   [**Hospital1 **] for rate control given the patient
s recent increased creatinine
   .
   # RHYTHM: Pt with hx of PAF, currently in bradycardic sinus rhythm
   -
   - Pt on Coumadin as outpatient and will restart this PM
   .
   #  DMII: Not on insulin as outpatient. HbA1C 7.3 ([**4-2**])
   - Will give home dose glipizide and cover the sugars with Humalog SS
   while in house.  Will hold home metformin.
   .
   #  Anemia: Unclear etiology. Longstanding history from prior records.
   Previous ferritin was normal.  No microcytosis. Mild elevated
   creatinine. Hemoglobin Electropheresis WNL (+FM hx for anemia)
   - Cont to monitor
   - Maintain Hct >30 given CAD hx
   .
   FEN: KVO/Replete PRN/Cardiac Diabetic Diet
   .
   ACCESS: PIV
   .
   PROPHYLAXIS:
   -DVT ppx with Coumadin
   -Bowel regimen with  Colace/Senna/milk of magnesia
   .
   Full Code
   COMM: Daughter [**First Name4 (NamePattern1) 927**] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 7860**]
   .
   DISPO: CCU for observation
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2159-9-18**] 12:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 74-year-old male who underwent right carotid stenting and is currently in the ICU for further observation. The patient has a history of coronary artery bypass grafting (CABG), cerebral vascular accident (CVA) with no residual effect, and bilateral carotid artery disease. 

The patient's vital signs are stable, with a temperature of 36.8Â°C, heart rate of 44 bpm, and blood pressure of 103/46 mmHg. The patient is receiving oxygen therapy, and his SpO2 is 96%. The patient's respiratory support is minimal, and his ABG results show a pH of 7.22. 

The patient's physical examination is notable for mild lower extremity edema, and his laboratory results show mild anemia, elevated creatinine, and abnormal liver function tests. The patient's INR is currently 1.2, and he is receiving warfarin therapy. 

The patient's medical plan includes maintenance of a systolic blood pressure between 90 and 120 mmHg, continuation of aspirin, clopidogrel, and warfarin therapy, and monitoring of his neurologic status. The patient will also be started on statin therapy and will have his Coumadin dose adjusted to achieve a therapeutic INR. 

Potential medical complications that can arise include:

1. Bleeding complications due to warfarin therapy and the patient's history of bleeding complications.
2. Cardiac complications, such as arrhythmias or heart failure, given the patient's history of coronary artery disease and recent cardiac procedures.
3. Neurological complications, such as stroke or transient ischemic attacks, given the patient's history of carotid artery disease and recent carotid stenting.
4. Respiratory complications, such as pneumonia or respiratory failure, given the patient's history of cardiac disease and recent cardiac procedures.
5. Gastrointestinal complications, such as gastrointestinal bleeding or constipation, given the patient's history of gastrointestinal disease and recent cardiac procedures.
6. Infection, given the patient's history of recent surgical procedures and the risk of surgical site infections.
7. Deep vein thrombosis (DVT) or pulmonary embolism (PE), given the patient's history of carotid stenting and the risk of DVT or PE with immobility.
8. Anemia or bleeding complications, given the patient's history of anemia and recent bleeding complications.

It is essential to closely monitor the patient's condition and adjust his medical plan accordingly to prevent or manage these potential complications."
